Does anyone have good examples or hypothesis of drug modifications that enabled change of pharmaco-dynamics of a drug? (NOT changing the kinetics) It would also be different from re-engineering (or re-purposing) of a drug because that is possible without any modification as well, i.e. by generating evidence in new indication.

More Amit Garg's questions See All
Similar questions and discussions